Transforming Growth Factor-β1 Modulates Extracellular Matrix Production, Proliferation, and Apoptosis of Endothelial Progenitor Cells in Tissue-Engineering Scaffolds
- 4 July 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 114 (1_suppleme) , I193-9
- https://doi.org/10.1161/circulationaha.105.001628
Abstract
Background— Valvular endothelial cells and circulating endothelial progenitor cells (EPCs) can undergo apparent phenotypic change from endothelial to mesenchymal cell type. Here we investigated whether EPCs can promote extracellular matrix formation in tissue engineering scaffolds in response to transforming growth factor (TGF)-β1. Method and Results— Characterized ovine peripheral blood EPCs were seeded onto poly (glycolic acid)/poly (4-hydroxybutyrate) scaffolds for 5 days. After seeding at 2×10 6 cells/cm 2 , scaffolds were incubated for 5 days in a roller bottle, with or without the addition of TGF-β1. After seeding at 15×10 6 cells/cm 2 , scaffolds were incubated for 10 days in a roller bottle with or without the addition of TGF-β1 for the first 5 days. Using immunofluorescence and Western blotting, we demonstrated that EPCs initially exhibit an endothelial phenotype (ie, CD31 + , von Willebrand factor + , and α–smooth muscle actin (SMA) − ) and can undergo a phenotypic change toward mesenchymal transformation (ie, CD31 + and α-SMA + ) in response to TGF-β1. Scanning electron microscopy and histology revealed enhanced tissue formation in EPC-TGF-β1 scaffolds. In both the 10- and 15-day experiments, EPC-TGF-β1 scaffolds exhibited a trend of increased DNA content compared with unstimulated EPC scaffolds. TGF-β1–mediated endothelial to mesenchymal transformation correlated with enhanced expression of laminin and fibronectin within scaffolds evidenced by Western blotting. Strong expression of tropoelastin was observed in response to TGF-β1 equal to that in the unstimulated EPC. In the 15-day experiments, TGF-β1–stimulated scaffolds revealed dramatically enhanced collagen production (types I and III) and incorporated more 5-bromodeoxyuridine and TUNEL staining compared with unstimulated controls. Conclusions— Stimulation of EPC-seeded tissue engineering scaffolds with TGF-β1 in vitro resulted in a more organized cellular architecture with glycoprotein, collagen, and elastin synthesis, and thus noninvasively isolated EPCs coupled with the pleiotropic actions of TGF-β1 could offer new strategies to guide tissue formation in engineered cardiac valves.Keywords
This publication has 11 references indexed in Scilit:
- From Stem Cells to Viable Autologous Semilunar Heart ValveCirculation, 2005
- The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissueBiomaterials, 2005
- Quantitative Evaluation of Endothelial Progenitors and Cardiac Valve Endothelial Cells: Proliferation and Differentiation on Poly-glycolic acid/Poly-4-hydroxybutyrate Scaffold in Response to Vascular Endothelial Growth Factor and Transforming Growth Factor β1Tissue Engineering, 2003
- Dynamic Rotational Seeding and Cell Culture System for Vascular Tube FormationTissue Engineering, 2003
- Human Umbilical Vein Endothelium-derived Cells Retain Potential to Differentiate into Smooth Muscle-like CellsPublished by Elsevier ,2003
- Mature Vascular Endothelium Can Give Rise to Smooth Muscle Cells via Endothelial-Mesenchymal TransdifferentiationCirculation Research, 2002
- Aortic Valve Endothelial Cells Undergo Transforming Growth Factor-β-Mediated and Non-Transforming Growth Factor-β-Mediated Transdifferentiation in VitroThe American Journal of Pathology, 2001
- Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivoNature Medicine, 2001
- Improved regional wall motion 6 months after direct myocardial revascularization (DMR) with the NOGA DMR system.Circulation, 2000
- Tissue engineering heart valves: Valve leaflet replacement study in a lamb modelThe Annals of Thoracic Surgery, 1995